Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: November 30, 2021
Accepted: July 12, 2022
Published online: September 16, 2022

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 5

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL

Abstract

Introduction: Medialization thyroplasty is a procedure indicated for treatment of impaired vocal fold movement. The purpose of this study was to identify variables associated with length of hospital stay (LOS), reoperation, and readmission in patients who underwent a medialization thyroplasty procedure for unilateral vocal cord paralysis. Methods: Adults who underwent unilateral medialization thyroplasty were identified using the 2017 to 2019 NSQIP databases via Current Procedural Terminology code 31591. Data collected included patient demographics, comorbidities, preoperative labs, American Society of Anesthesiologists classification, inpatient status, operative length, and complications. Univariate and multivariate logistic regression were used to analyze effects on total LOS, reoperation, and readmission. Results: 320 patients were identified, with a mean age of 61 years (95% Cl 59.4–62.7) and a female-to-male ratio of 1.1:1. Forty-two (13.1%) patients reported dyspnea as a preoperative symptom. Seven patients (2.2%) reported postoperative complications, 2 with multiple complications: 2 surgical site infections, 2 pneumonias, 2 unplanned intubations, 2 myocardial infarctions, 1 septic shock, 1 cardiac arrest, 1 ventilator use (>48 h), and 1 acute renal failure. Fifty-one (15.9%) were inpatient procedures, with a mean LOS of 1.43 days (95% CI 0.92–1.94). Preoperative functional status and bilirubin were significantly associated with longer LOS (p < 0.001). There were 6 (1.9%) readmissions and 2 (0.6%) reoperations. In univariate analysis, dyspnea varied with reoperation which is important to note in this patient population with glottic insufficiency. Conclusion: Medialization thyroplasty is a procedure with a low risk of mortality. However, preexisting patient comorbidities are associated with an increased risk of postoperative complications and an increased length of stay.

© 2022 S. Karger AG, Basel

References Misono S, Merati AL. Evidence-based practice. Evaluation and management of unilateral vocal fold paralysis. Otolaryngol Clin North Am. 2012;45(5):1083–108. Rosenthal LHS, Benninger MS, Deeb RH. Vocal fold immobility: a longitudinal analysis of etiology over 20 years. Laryngoscope. 2007;117(10):1864–70. Culp JM, Gaurex P. Recurrent Laryngeal Nerve Injury [Internet]. Treasure Island, Fl: StatPearls Publishing LLC; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560832/. Crowson MG, Tong BC, Lee HJ, Song Y, Misono S, Jones HN, et al. Vocal fold paralysis/paresis as a marker for poor swallowing outcomes after thoracic surgery procedures. Dysphagia. 2019;34(6):904–15. Abraham MT, Gonen M, Kraus DH. Complications of type I thyroplasty and arytenoid adduction. Laryngoscope. 2001;111(8):1322–9. Garber D, Wandell GM, Gobillot TA, Merati A, Bhatt NK, Giliberto JP. Safety and predictors of 30-day adverse events of laryngeal framework surgery: an analysis of ACS-NSQIP data. Laryngoscope. 2022;132(7):1414–20. Flint PW, Schindler JS, Cummings CW. Medialization Thyroplasty. Cummings otolaryngology: head and neck surgery. 2nd ed. Elsevier Ltd; 2021. p. 906. Watanabe K, Hirano A, Honkura Y, Kashima K, Shirakura M, Katori Y. Complications of using Gore-Tex in medialization laryngoplasty: case series and literature review. Eur Arch Oto-Rhino-Laryngology. 2019;276(1):255–61. Ryu IS, Nam SY, Han MW, Choi SH, Kim SY, Roh JL. Long-term voice outcomes after thyroplasty for unilateral vocal fold paralysis. Arch Otolaryngol − Head Neck Surg. 2012;138(4):347–51. Overton L, Adams K, Shah RN, Buckmire RA. Longitudinal voice outcomes after Type i Gore-tex thyroplasty for nonparalytic glottic incompetence. Ann Otol Rhinol Laryngol. 2017;126(1):14–9. van den Broek EMJM, Heijnen BJ, Hendriksma M, van de Kamp-Lam VAH, Verhagen TO, Langeveld APM, et al. Bilateral medialization thyroplasty in patients with vocal fold atrophy with or without sulcus. Eur Arch Oto-rhino-laryngology. 2020;277(7):2023–9. American College of Surgeons National Surgical Quality Improvement Program. About ACS NSQIP [Internet]. [cited 2021 Feb 13]. Available from: https://www.facs.org/quality-programs/acs-nsqip/about. Cotter CS, Avidano MA, Crary MA, Cassisi NJ, Gorham MM. Laryngeal complications after type 1 thyroplasty. Otolaryngol - Head Neck Surg.. 1995;113(6):671–3. Suehiro A, Hirano S, Kishimoto Y, Tanaka S, Ford CN. Comparative study of vocal outcomes with silicone versus Gore-Tex thyroplasty. Ann Otol Rhinol Laryngol. 2009;118(6):405–8. Chiulli LC, Stephen AH, Heffernan DS, Miner TJ. Association of medical comorbidities, surgical outcomes, and failure to rescue: an analysis of the Rhode Island Hospital NSQIP database. J Am Coll Surg. 2015;221(6):1050–6. Patel J, Boon M, Spiegel J, Huntley C. Safety of outpatient type 1 thyroplasty. Ear, Nose Throat J. 2020;100(5 suppl):608S−613S. Hung YC, Wolf JH, D’Adamo CR, Demos J, Katlic MR, Svoboda S. Preoperative functional status is associated with discharge to nonhome in geriatric individuals. J Am Geriatr Soc. 2021;69(7):1856–64. Chang CJ, Tam HP, Ko WJ, Tsai PR. Predicting hospital mortality in adult patients with prolonged stay (>14 days) in surgical intensive care unit. Minerva Anestesiol. 2013 Aug;79(8):843–52. Ali B, Choi EE, Barlas V, Petersen TR, Menon NG, Morrell NT. Risk factors for 30-day mortality after head and neck microsurgical reconstruction for cancer: NSQIP analysis. OTO Open. 2021;5(3). Haidar YM, Kuan EC, Verma SP, Goddard JA, Armstrong WB, Tjoa T. Free flap versus pedicled flap reconstruction of laryngopharyngeal defects: a 10-year national surgical quality improvement program analysis. Laryngoscope. 2019;129(1):105–12. Chen MH, Chang PMH, Chen PM, Tzeng CH, Chu PY, Chang SY, et al. Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol. 2009;135(12):1783–90. Hodari A, Tsiouris A, Eichenhorn M, Horst M, Rubinfeld I. Exploring national surgical quality improvement program respiratory comorbidities: developing a predictive understanding of postoperative respiratory occurrences, Clavien 4 complications, and death. J Surg Res. 2013 Aug 1;183(2):663–7. Article / Publication Details

First-Page Preview

Received: November 30, 2021
Accepted: July 12, 2022
Published online: September 16, 2022

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 5

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL